Authors
Latest:
Recognizing and Addressing Psychiatric Implications of Sleep DisordersWhat sleep disorders are common in older adults and what are the associated risk factors and correlates?
Latest:
Interpret at Your Own Risk: Medical Students as Ad-Hoc Interpreters and Vicarious TraumaWe must educate and provide resources for medical students and institutions.
Latest:
How Cities Can Boost Brain CapitalIn a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.
Latest:
Stitching Time: Women and Fiber Art in Psychiatric HistorySewing, weaving, knitting, crochet, and needlework can all be soothing, expressive, and communal. How did women patients in psychiatric history harness the therapeutic and political potential of fiber art? What can we learn about life in psychiatric institutions from their work?
Latest:
Honoring a BrotherJoseph Cofrancesco Jr, MD, MPH, remembers his brother who died of complications from COVID-19, intubated, sedated, and alone.
Latest:
Issues in Regulating DTxWe need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Latest:
Building the Bridge Between Psyche and Soma: 2021 Sigourney Award WinnerPsychoanalysis and dermatology: this Sigourney Award Winner is bridging the 2 specialties.
Latest:
Interpreting Digital Information in Forensic SettingsHow can digital therapeutics overcome barriers to psychiatric treatment in forensic settings?
Latest:
Psychiatrists Call for End to Cruel and Harmful Immigration PolicyThe Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Latest:
REMS for Psychiatric Medications: The Good, the Bad, and the UglySession at the 2023 American Psychiatric Association Annual Meeting shares insights on REMS for psychiatric medications.
Latest:
The Safety of Psychostimulants or Atomoxetine for Patients With Psychotic DisordersEvidence indicates that children and adolescents with ADHD have a more than 4-fold increased risk of schizophrenia spectrum and other psychotic disorders in adulthood compared with the general population.
Latest:
Long-Acting Injectables and a Team-Driven Approach for Schizophrenia TreatmentHow can you best discuss long-acting injectable options with your patients living with schizophrenia?
Latest:
Conventional and Integrative Approaches to Treating Anxiety in PregnancyWomen should be provided with multiple options for treatment if they decide to engage in mental health care during this critical period.
Latest:
A Dialogue on Psychosis and TraumaJoining together to discuss psychosis, 3 British experts discuss various ways to respond to and help people who have experienced both trauma and psychosis.
Latest:
The Expanding Reach of the South African Psychoanalytical AssociationThanks to a recent Sigourney Award, this association is achieving well-deserved recognition.
Latest:
The Perinatal Mental Health CrisisPerinatal mood and anxiety disorders affect 1 in 5 of perinatal individuals who are pregnant or up to 1 year postpartum. Over the past 2 decades, the US has seen an alarming rise in these disorders.
Latest:
Vaccine Mandate Exemptions for Anxiety: Ethical and Practical ConsiderationsDoes anxiety justify an exemption from vaccine mandates among health care workers?
Latest:
Postpartum Psychosis: Complicated but Treatable Psychiatric EmergencyPostpartum psychosis has a complicated presentation and is often misdiagnosed or missed in patients.
Latest:
Get Cozy and Keep SleepingHere’s how we can help improve quality of sleep in both our patients and ourselves.
Latest:
Building Brain Resilience: A Multi-Level Systems ApproachBeyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.
Latest:
Empowering Advanced Practice Providers to Adopt Routine Screening for Tardive DyskinesiaThis article was developed and sponsored in collaboration with Neurocrine Biosciences, Inc. Amy LaCouture, RN, BSN, PMHNP-BC and Linda Trinh, DNP, MPH, FNP-C, PMHNP-BC have been compensated by Neurocrine Biosciences, Inc. to author this article and share their perspectives.
Latest:
What Can Be Done About Anxious and Violent Men?During National Men’s Health Month, take time to consider the unique mental health needs of male patients.
Latest:
Reducing Opioid-Involved Overdose Deaths: States’ Prevention and Response EffortsIn this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.
Latest:
The Perinatal Mental Health CrisisPerinatal mood and anxiety disorders affect 1 in 5 of perinatal individuals who are pregnant or up to 1 year postpartum. Over the past 2 decades, the US has seen an alarming rise in these disorders.
Latest:
Antidepressant Response: What’s DNA Got to Do With It?Research using data from the All of Us Research Program seeks to solve the mystery of what makes medications work for some and not others.
Latest:
Addressing Alcohol or Cannabis Use in Patients With Anxiety DisordersIn this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.
